Colorectal Cancer | Tumor

CURE’s colorectal cancer page is an extensive resource of cancer information featuring the latest colorectal cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on colorectal cancer.

Study Shows Poor Outcomes in BRAF V600E-Mutant Metastatic CRC

January 26th 2025, 7:00pm

Article

Synchronous metastases did not affect survival in resected BRAF V600E-mutated metastatic colorectal cancer.

The BREAKWATER Trial Explores Braftovi, Erbitux and Chemo in BRAF V600E+ mCRC

January 26th 2025, 3:00pm

Video

Dr. Scott Kopetz discusses the BREAKWATER trial investigating Braftovi and Erbitux plus chemo in those with BRAF V600E+ metastatic colorectal cancer.

Aspirin May Reduce Recurrence in PI3K-mutated Colorectal Cancer

January 25th 2025, 3:02pm

Article

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance of upfront genomic testing.

Second Cancer Risk Heightened After Appendiceal Adenocarcinoma Diagnosis

January 24th 2025, 5:18pm

Article

Adults with primary primary appendiceal adenocarcinoma face a higher risk of developing a second primary cancer, including colorectal and prostate cancers.

Understanding the Concept of MRD for Patients With Cancer

January 22nd 2025, 4:00pm

Article

Dr. Christopher Flowers discusses MRD testing in cancer care, why this is an important concept to understand and how it relates to recurrence in patients.

The Significance of the Subcutaneous Opdivo FDA Approval in Solid Tumors

January 20th 2025, 2:00pm

Article

Dr. Balazs Halmos discusses the significance of the approval of subcutaneous Opdivo and what this treatment formulation means for those with solid tumors.

Carrying the Torch: From Colorectal Cancer Survivor to Advocate

January 17th 2025, 6:00pm

Article

As someone who has overcome colorectal cancer, I reflect on the support I received from others and vow to continue their legacy of advocacy.

FDA Approves Lumakras with Vectibix in KRAS G12C+ Colorectal Cancer

January 16th 2025, 11:50pm

Article

The FDA has approved Lumakras with Vectibix for adults with KRAS G12C-mutated metastatic colorectal cancer who received chemotherapy.

How I Navigated a Colon Cancer Diagnosis at Age 34

December 30th 2024, 6:00pm

Article

Receiving a diagnosis of colon cancer at age 34 was such a shocking experience, but it has helped me become more strong-willed.

Unparalleled Devotion to Her Patients With Cancer

December 28th 2024, 3:00pm

Article

Even after a personal connection to cancer, oncology nurse Megan has embraced the cancer space as her passion.